US food tech startup The Every Company has raised $55M in Series D funding to expand its precision-fermented egg proteins, ...

Colossal’s purchase of ViaGen, known for cloning pets of celebrities, bolsters the biotech firm’s tools for de-extinction and ...

In a world first, a bespoke gene-editing therapy benefited one child. Now researchers plan to launch a clinical trial of the approach ...

Colossal Biosciences, which has brought to life a small pack of genetically modified dire wolves, has acquired cloning company Viagen.